Mutation analysis was performed on 50 known cancer related genes and expression of Bcl-2, Bcl-xl, Survivin, P-S6, LC3B and P53, previously identified to play a role in chondrosarcoma [26–30], was determined using immunohistochemistry. The gene discussed is MAP1LC3B; the disease is chondrosarcoma.